Results 81 to 90 of about 21,997 (216)

Lipoprotein(a), Lp(a)

The Journal of Japan Atherosclerosis Society, 1996
openaire   +2 more sources

A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia: Reversal by ApoC-III Inhibition. [PDF]

JACC Basic Transl Sci
Lin L, Brush MN, Nelson CB, Alexander VJ, Xia S, Gordts PLSM, Tsimikas S.   +6 more
europepmc   +1 more source

Cardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS)

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
Su Jen Chua, Xinyi Wu, Tahani Al Kindi, Bulent O. Yildiz, Aya Mousa, Loyal Pattuwage, Helena Teede, Anju E. Joham, Chau Thien Tay   +8 more
wiley   +1 more source

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention. [PDF]

Methodist Debakey Cardiovasc J
Bene-Alhasan Y, Nambi V, Abushamat LA, Ballantyne CM.   +3 more
europepmc   +1 more source

Macrophage Lipid Homeostasis Drives IVDD via a Senescence‐Dependent Impairment of Efferocytosis

Cell Proliferation, EarlyView.
Intervertebral disc degeneration (IVDD) has been a leading cause of low back pain and lacks disease‐modifying therapies. Although dysregulated disc lipid metabolism is implicated, its impact on the immune microenvironment, particularly macrophages, remains unknown.
Jinyu Wang, Shiyong Ling, Qi Wang, Xuege Qiao, Jianpeng Xing, Siyang Ji, Linhui Han, Chen Yan, Zhishen Niu, Lei Yuan, Baolian Zhao, Kaiqiang Sun, Jiangang Shi   +12 more
wiley   +1 more source

Lower lipoprotein(a) levels in patients with acute lacunar infarction. [PDF]

IBRO Neurosci Rep
Chen X, Chen N, Zhu L, Huang Q, Jiang F.
europepmc   +1 more source

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest, Priyanka Majety, Stéphanie B. Mayer, Om P. Ganda   +3 more
wiley   +1 more source

Lipoprotein(a) and Incident Aortic Stenosis Over 30 Years: The ARIC Study. [PDF]

Arterioscler Thromb Vasc Biol
Zubirán R, Wolska A, Remaley AT.
europepmc   +1 more source

Oleanolic Acid‐Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Chronic kidney disease (CKD) is a major complication of type 2 diabetes mellitus (T2DM), driven in part by oxidative stress and the accumulation of advanced glycation end products (AGEs). Oleanolic acid (OA), a natural triterpene present in olive‐derived matrices, may modulate AGE metabolism.
Aída García‐González, Alejandro Matamoros‐Domínguez, Juan Manuel Espinosa‐Cabello, Gisela Pérez‐Muñoz, Manuel Jesús León Aranda, María Del Carmen Roque‐Cuellar, Silvia García‐Rey, Andrés Jiménez‐Sánchez, Antonio Jesús Martínez‐Ortega, Miguel Ángel Mangas‐Cruz, Isabel Cerrillo, Javier S. Perona, Pedro Pablo García‐Luna, Elena María Yubero‐Serrano, José María Castellano   +14 more
wiley   +1 more source

Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopy. [PDF]

Atheroscler Plus
Kojima K, Tanaka Y, Fukumoto K, Ebuchi Y, Nishiwaki T, Kurito N, Tomimatsu S, Hotsubo Y, Nagao T, Sumida R, Mizobuchi S, Migita S, Miyagawa M, Hori K, Koyama Y, Arai R, Migita S, Sudo M, Fukamachi D, Okumura Y.   +19 more
europepmc   +1 more source